Children with IBD
Risk and Safety
Not everyone is at the same risk of serious COVID-19 disease. Children and adolescents are at low risk of getting COVID-19. They also tend to have more mild symptoms if they do get the disease.
If a young person is on immunosuppressant medications, we cannot say that there is no added risk, but their young age, good general health, and good disease control should put them at a lower risk than the older adults. Beyond age, COVID-19 risk factors often relate to cardiovascular disease and blood pressure.
Children with inflammatory bowel disease should continue to be careful and avoid contact with others, but there is data that suggests medications may not increase a patient’s risk for bad outcomes if they are exposed to COVID-19.
Watch the 4-minute video to learn more about about the risk of COVID-19 among children who have Crohn's or colitis.
Watch the 3-minute video below learn from gastroenterologist and infectious disease experts about the safety of medication use in children with during the COVID-19 pandemic.
Caring for your Child during the pandemic
If your child is immunocompromised because of Crohn's or colitis, then try to stay away from other people as much as possible, and especially keep them away from large gatherings.
Families should discuss with their healthcare providers the best options for administering medications to their children during the pandemic.
For young patients that are experiencing pain and or fever, Acetaminophen (Tylenol) is safe to use. However, follow the directions on the package and speak with your healthcare provider if you have liver problems.
For more expert guidance, visit our Recommenations for IBD page.
reopening of schools and economy
For expert guidance on if your child should return to school and take part in extra-curricular activities, please click here.
Like our COVID-19 & IBD content?
Join Dr. Gil Kaplan and Dr. Eric Benchimol’s Gutsy Walk team to show your support.